FDA authorizes Pfizer COVID-19 vaccine for kids ages 12 to 15

The U.S. Food and Drug Administration on Monday expanded emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine in the United States for older children ages 12 to 15. Vaccines could begin for the new eligible group as early as this week, pending CDC approval and state health review.